AB0267 Treatment paradigms in real-world practice: biologic agent use prior to and after discontinuation of abatacept in the action study
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.1392
Abstract: Background ACTION is a 2-year, observational study of patients (pts) with moderate-to-severe RA who initiated IV abatacept (ABA) in Canada and Europe (NCT02109666). Objectives To determine pt biologic (b)DMARD use prior to initiation and after… read more here.
Keywords: discontinuation; biologic failure; myers squibb; bristol myers ... See more keywords